# Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)

> **NCT05529524** · — · COMPLETED · sponsor: **The Lymphoma Academic Research Organisation** · enrollment: 6 (actual)

## Conditions studied

- Follicular Lymphoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05529524
- **Lead sponsor:** The Lymphoma Academic Research Organisation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-07
- **Primary completion:** 2024-01-22
- **Final completion:** 2024-01-22
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05529524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05529524, "Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT05529524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*